Multiple endocrinological failures as a clinical presentation of a metastatic lung adenocarcinoma.
Taieb AchPerrine WojewodaFlora ToulletRoxane DuclouxVéronique AvérousPublished in: Endocrinology, diabetes & metabolism case reports (2020)
Adrenal metastasis is a common location in lung adenocarcinoma; however, metastatic involvement of the pituitary stalk remains a rare occurrence, especially as a leading presentation to diagnose lung cancer. The posterior pituitary and the infundibulum are the preferential sites for metastases, as they receive direct arterial blood supply from hypophyseal arteries. Patients diagnosed with diabetes insipidus due to pituitary stalk thickness should be considered as a metastasis, after exclusion of the classical systemic and infectious diseases. The diagnosis of an endocrinological metastatic primary lung adenocarcinoma for patients without respiratory symptoms is often delayed due to a lack of correlation between endocrinological symptoms and lung cancer. The main originality of our case is the concomitant diagnosis of both endocrinological failures, as it was initiated with a diabetes insipidus and followed by an acute adrenal insufficiency.
Keyphrases
- end stage renal disease
- squamous cell carcinoma
- small cell lung cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiovascular disease
- type diabetes
- peritoneal dialysis
- prognostic factors
- risk assessment
- liver failure
- depressive symptoms
- hepatitis b virus
- optical coherence tomography
- sleep quality
- growth hormone
- patient reported outcomes
- extracorporeal membrane oxygenation